- Home
- Programs and Groups
- Shared Resources
- Faculty
- Clinical Trials
- Tumor Registry
- Education
- About DCI
Quick Links
Pediatric Clinical Trials - Pediatric Brain Tumor
If you would like to inquire about all open trials, please contact 919-684-3401.
Items 1 - 7 of 7
Items 1 - 7 of 7
PBTC-N11: Immunologic Profile of Patients with Newly Diagnosed Medulloblastoma at Initial Diagnosis and During Standard Radiation and Chemotherapy
Principal Investigator: Sridharan Gururangan
Phase: N/A
Phone: 919-668-5364
Principal Investigator: Sridharan Gururangan
Phase: N/A
Phone: 919-668-5364
PBTC-026: A Feasibility Study of SAHA combined with Isotretinoin and Chemotherapy in Infants with Embryonal Tumors of the Central Nervous System
Principal Investigator: Sridharan Gururangan
Phase: Other
Phone: 919-668-5364
Principal Investigator: Sridharan Gururangan
Phase: Other
Phone: 919-668-5364
PBTC-029 Phase I and Pharmacokinetic Study of AZD6244 for Recurrent or Refractory Pediatric Low Grade Glioma
Principal Investigator: Sridharan Gururangan
Phase: Phase I
Phone: 919-668-5364
Principal Investigator: Sridharan Gururangan
Phase: Phase I
Phone: 919-668-5364
PBTC-031: Phase I and Pharmacokinetic Trial of PTC299 in Pediatric Patients with Refractory or Recurrent CNS Tumor
Principal Investigator: Sridharan Gururangan
Phase: Phase I
Phone: 919-668-5364
Principal Investigator: Sridharan Gururangan
Phase: Phase I
Phone: 919-668-5364
PBTC-033 A Phase I/II Study of ABT-888, an Oral Poly (ADP-ribose) Polymerase Inhibitor, and Concurrent Radiation Therapy, Followed by ABT-888 and Temozolomide, in Children with Newly Diagnosed diffuse Pontine Gliomas (DIPG)
Principal Investigator: Sridharan Gururangan
Phase: Phase I
Phone: 919-668-5364
Principal Investigator: Sridharan Gururangan
Phase: Phase I
Phone: 919-668-5364
ACNS0332 Efficacy of Carboplatin Administered Concomitantly with Radiation and Isotretinoin as a Pro-Apoptotic Agent in Other Than Average Risk Medulloblastoma/PNET Patients
Principal Investigator: Susan Kreissman
Phase: Phase III
Phone: 919-684-3401
Principal Investigator: Susan Kreissman
Phase: Phase III
Phone: 919-684-3401
Recurrent Medulloblastoma and Primitive Neuroectodermal Tumor Adoptive T Cell Therapy during Recovery from Myeloablative Chemotherapy and Hematopoietic Stem Cell Transplantation
Principal Investigator: Duane Mitchell
Phase: Phase I
Phone: 919-668-5364
Principal Investigator: Duane Mitchell
Phase: Phase I
Phone: 919-668-5364
